Key result
Troponin-I sustains >93% sensitivity up to 72 hours post-infarct, outlasting myoglobin and CKMB.
Why the study?
The diagnostic sensitivity of troponin-I, myoglobin, and CKMB mass concentration for acute myocardial infarction at different time frames was not well established.
Observational (n=87)
Answers are grounded in this paper and cite their sources.
These markers lack early sensitivity for AMI; supports time-specific use but leaves open prospective validation of guidelines.
Myoglobin, creatine kinase-MB (CKMB) mass concentration and troponin-I are newer biochemical markers for the diagnosis of acute myocardial infarction (AMI). We conducted a prospective study to formulate a model for the collective interpretation of these three markers in the diagnosis of AMI. Eighty-seven patients with AMI had serial serum samples taken to establish the time-frame sensitivity of individual markers. None of the markers had a good sensitivity within the first 4 h of infarction. Myoglobin and CKMB (mass) had sensitivities of 92.3% and 96.2%, respectively, at 4-8 h post infarct. CKMB (mass) and troponin-I had sensitivities >92% at 8-24 h. Troponin-I maintained sensitivity >93% until 72 h. A guideline was formulated based on the results. Our data suggest that troponin-I, myoglobin and CKMB (mass) yield satisfactory diagnostic sensitivity when used with reference to specific time frames. The combined use of these markers can provide valuable information for clinicians in managing AMI patients.
No takes yet. Share an insight, caveat, or question.
Alexander Chiu (1999) conducted an observational in Acute myocardial infarction (n=87). Myoglobin, CKMB mass, and troponin-I was evaluated on Sensitivity of individual markers at specific time frames. Myoglobin and CKMB mass demonstrated sensitivities of 92.3% and 96.2% at 4-8 hours post-infarct, whereas troponin-I maintained a sensitivity >93% up to 72 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: